National MS Society

• Efficacy of Seated Physical Activity INtervention(SPIN) for Wheelchair Users With Multiple Sclerosis

  Collaborator, Not yet recruiting, 100 people

• NCT03896217

  Collaborator, Phase 2, Completed, 40 people, Mar 29, 2019

• NCT03500289

  Collaborator, Phase 1/2, Completed, 18 people, Apr 18, 2018

• NCT03166800

  Collaborator, Phase 1/2, Terminated, 9 people, May 25, 2017

• NCT03051646

  Collaborator, Early phase 1, Completed, 12 people, Feb 14, 2017

• NCT02133664

  Collaborator, Phase 1/2, Completed, 54 people, May 8, 2014

• NCT01910259

  Collaborator, Phase 2, Completed, 445 people, Jul 29, 2013

• NCT01451593

  Collaborator, Phase 2, Completed, 92 people, Oct 13, 2011

• NCT00682929

  Collaborator, Phase 1/2, Terminated, 41 people, May 23, 2008

• NCT00501943

  Collaborator, Phase 2, Completed, 43 people, Jul 16, 2007

• NCT00467584

  Collaborator, Phase 3, Terminated, 62 people, Apr 30, 2007

• NCT00418145

  Collaborator, Phase 3, Terminated, 16 people, Jan 4, 2007

• NCT00405353

  Collaborator, Phase 1/2, Completed, 10 people, Nov 30, 2006

• NCT00043264

  Collaborator, Phase 2, Completed, 40 people, Aug 8, 2002

Sources: clinicaltrials.gov

• Oligodendrocyte precursor cell death does not contribute to lifelong population homeostasis

  FG-2307-42173

• Walking and strength outcomes of targeted hip resistance training may be predicted by both MRI and clinical measures in multiple sclerosis

  Oct 12, 2026

• Reduced perivascular diffusion in multiple sclerosis is associated with aging, disease duration, and mobility impairment

  MB-2205-39515, JF-1907-34355, Oct 4, 2026

• Paralemmin 2 is a shared, alternatively-spliced regulator of axon initial segments and paranodal junctions in oligodendrocytes

  NMSS-TA-2403-42997, Aug 23, 2026

• Temporal changes in metabolism guide oligodendrocyte precursor cell dynamics in aging and multiple sclerosis

  Aug 7, 2026

• Association between neural-drive variability and motor function in middle-aged and older adults

  RG-2206-39688, Jul 30, 2026

• Potential Role of Nociceptin/Orphanin FQ in the Progression of Multiple Sclerosis

  RG-2206-39621, Jul 8, 2026

• Oligodendrocyte Piezo2 is a regulator of age-dependent myelin integrity and dysregulated in multiple sclerosis

  RFA-2203-39300, Jun 20, 2026

• Aged oligodendrocyte progenitors retain the capacity to respond to an inflammatory insult

  SCR_025078, Jun 10, 2026

• Beyond chronological age: biological aging and its relevance for motor and cognitive function in multiple sclerosis

  MB-2107–38295, May 19, 2026

• Reducing frailty in frail people with multiple sclerosis: Feasibility of a 6-week multimodal exercise training program

  MB-1807-31633, Apr 15, 2026

• The Role of Meningeal Lymphatic Vessels and Perivascular Cerebrospinal Fluid Flow in Age-Related Processing Speed Decline

  RG-1507-04951, Apr 7, 2026

• Brain Age Estimation on T2-FLAIR Scans for Application to Multiple Sclerosis

  Apr 1, 2026

• Clocks out of sync: Increased epigenetic aging variability in multiple sclerosis

  BI-2306-41591, Mar 30, 2026

• Effects of nordic walking in individuals with Parkinson's disease: A review of systematic reviews

  Mar 18, 2026

• Randomized controlled trial of a remotely-delivered exercise training program in older adults with multiple sclerosis: Secondary effects on cognition, symptoms, and quality of life

  Mar 1, 2026

• Premyelinating Oligodendrocyte Survival Governs CNS Remyelination

  FF-2312-42544, Feb 23, 2026

• Accelerated metabolomic aging and its association with social determinants of health in multiple sclerosis

  JF-2007-36755, Feb 20, 2026

• Cardiorespiratory response to different aerobic exercise modalities in people with advanced multiple sclerosis

  PP 1904-33937, Feb 10, 2026

• Myelin is repaired by constitutive differentiation of oligodendrocyte progenitors

  FG-1708-28962, Jan 22, 2026

Sources: api.crossref.org, pubmed.ncbi.nlm.nih.gov, openalex.org

• Menopause and neurological disorders: a roadmap for research

  Grants or research support, Aug 10, 2026

• Proteomic Age Acceleration in Multiple Sclerosis Precedes Symptom Onset and Associates with Severity

  Consulting or advice, Fees or honoraria, Grants or research support, Apr 20, 2026

• Expert Opinion on Age-Related Sex Hormone Changes and Hypogonadism in People With Multiple Sclerosis: A Delphi Consensus Program

  Grants or research support, Feb 26, 2026

• A description of processing speed, learning and memory in people with multiple sclerosis aged 55

  Grants or research support, Mar 31, 2025

• Randomised controlled trial of intermittent calorie restriction in people with multiple sclerosis

  Grants or research support, Jan 16, 2025

• The ageing central nervous system in multiple sclerosis: the imaging perspective

  Fees or honoraria, Grants or research support, Nov 4, 2024

• Non-neurological factors associated with serum neurofilament levels in the United States population

  Grants or research support, Apr 8, 2024

• The Brain Health Imperative in the 21st Century-A Call to Action: The AAN Brain Health Platform and Position Statement

  Consulting or advice, Fees or honoraria, Grants or research support, Board or leadership role, Sep 26, 2023

• HACA3: A unified approach for multi-site MR image harmonization

  Grants or research support, Aug 14, 2023

• Intermittent calorie restriction alters T cell subsets and metabolic markers in people with multiple sclerosis

  Grants or research support, Jul 8, 2022

Sources: pubmed.ncbi.nlm.nih.gov

• A description of processing speed, learning and memory in people with multiple sclerosis aged 55

  Multiple sclerosis and related disorders, Apr 23, 2025

• Intermittent calorie restriction alters T cell subsets and metabolic markers in people with multiple sclerosis

  EBioMedicine, Jul 12, 2022